Monsanto's head-on competitor is the giant conglomerate E. I. du Pont de Nemours (DD).
Although the agricultural unit is but a portion of its business, DuPont is growing it rapidly."The competition with Monsanto is likely to be fierce," wrote Morningstar analyst Min Tang-Varner in a Jan. 26 research note. In 2010, DuPont "successfully increased its North American corn and soybean market shares, thanks to its excellent marketing and distribution channels, as well as mishaps (that set back product launches by) Monsanto's SmartStax and Roundup Ready 2 Yield. But Monsanto remains a formidable opponent, in our opinion, and the outcome of this competition is far from certain." Du Pont is aggressively developing its agriculture and nutrition segment, which includes the development and marketing of crop protection chemicals such as insecticide, herbicide and fungicide. "DuPont leveraged its knowledge of corn and soybeans and actively developed genetically modified seed technologies" after a 1999 merger with Pioneer, a leader in that field, Tang-Varner said, and it is developing genetically modified seeds. "We expect this segment to account for the lion's share of future growth for the company in both North America and emerging markets. Du Pont is going strong. It recently reported 2010 earnings of $3.28 per share, up 62% from a challenging year in 2009. Morningstar has a $42 price target on it, equal to 12 times its 2010 earnings per share. It pays a 2.99% dividend yield. Its shares are up 9% this year and 66% over the past year. The company has a market value of $50 billion. Analysts give it nine "buy," ratings, one "outperform" and five "holds."
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV